AKIN GUMP STRAUSS HAUER & FELD

Lobbying for AMGEN USA, INC. · Biotechnology healthcare products.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Taxation/Internal Revenue Code

Issues related to international tax.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem